{"Title": "High cost of new drugs", "Year": 2016, "Source": "BMJ (Online)", "Volume": "354", "Issue": null, "Art.No": null, "PageStart": null, "PageEnd": null, "CitedBy": 4, "DOI": "10.1136/bmj.i4136", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84980315323&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Antiviral Agents", "Benzimidazoles", "Cost-Benefit Analysis", "Costs and Cost Analysis", "Drug Costs", "Drug Industry", "Fluorenes", "Hepatitis C", "Humans", "Sofosbuvir", "United Kingdom"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 2, "EID": "2-s2.0-84980315323", "SubjectAreas": [["Medicine (all)", "MEDI", "2700"]], "AuthorData": {"7003892124": {"Name": "Mazzucato M.", "AuthorID": "7003892124", "AffiliationID": "60017317", "AffiliationName": "Science Policy Research Unit, University of Sussex"}}}